Kenji Nakahama
4PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Aug 22, 2023
Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer.Kenji Nakahama, Motohiro Izumi, Naoki Yoshimoto
|Apr 06, 2023
Vimentin expression correlates with immune checkpoint inhibitor efficacy in non-small cell lung cancer.Kenji Nakahama, Motohiro Izumi, Naoki Yoshimoto
|Jul 09, 2022
Association of thyroid transcription factor-1 with the efficacy of immune-checkpoint inhibitors in patients with advanced lung adenocarcinoma.Kenji Nakahama, Hiroyasu Kaneda, Masahiko Osawa
|Jun 20, 2022
Vascular endothelial growth factor receptor 2 expression and immunotherapy efficacy in non-small cell lung cancer.Kenji Nakahama, Hiroyasu Kaneda, Masahiko Osawa
Pageof 1
